You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Phase 1 first-in-human study of dalutrafusp alfa, an anti–CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Phase 1 first-in-human study of dalutrafusp alfa, an anti–CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: February 2023 to June 2025

AbstractFullPdf
Feb 2023674690246
Mar 202329930581
Apr 202315416061
May 202311811938
Jun 202312512533
Jul 202313113130
Aug 202315115028
Sep 2023828527
Oct 2023818125
Nov 2023979735
Dec 2023868730
Jan 2024848442
Feb 2024636539
Mar 2024595975
Apr 2024616159
May 2024606042
Jun 2024535432
Jul 2024697130
Aug 2024353424
Sep 2024596234
Oct 2024404425
Nov 2024575831
Dec 2024525337
Jan 2025555528
Feb 2025717126
Mar 2025555538
Apr 2025767644
May 2025667164
Jun 2025343417
Total304730971321